AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants
Parents of children with intellectual disabilities have long been frustrated by intelligence quotient (IQ) testing that tells them little to nothing about the long-term learning potential of their children. That’s because these tests are scored according to the mean performance of children without disabilities. The result is that the raw scores of many children with
Full Post: New system of scoring IQ tests taken by children with fragile X syndrome
As World AIDS Day 2008 approaches, a coalition of hundreds of HIV/AIDS medical care providers and advocates, representing dozens of organizations, today sent a letter to Dr. Margaret Chan, Director General of the World Health Organization (WHO), urging an end to harmful single-dose HIV/AIDS treatment as a recommended treatment for expectant mothers and infants worldwide.
The letter expresses concern over the use and recommendation of short-course therapy (such as single-dose Nevirapine and/or Zidovudine) for expectant and breastfeeding mothers as short-course treatment-standard practice in many resource-constrained settings has been proven to be less effective at preventing mother-to-child HIV transmission as well as less safe for both mother and child than full-course Highly Active Antiretroviral Therapy (HAART).
Calling for an immediate revision of WHO’s treatment guidelines to reflect current knowledge regarding the dangers of single-dose treatment is a broad coalition led by AIDS Healthcare Foundation (AHF). Supporters include Dr. Homayoon Khanlou , AHF’s Chief of Medicine, USA; Dr. Julio Montaner ; Dr. Robert R. Redfield Jr. , Director of the HIV Program at the University of Maryland, School of Medicine; Dr. Jane Aronson , CEO/Founder of Worldwide Orphans Foundation; Dr. Sophia Mengistu , Country Director/Ethiopia, Worldwide Orphans Foundation; Dr. Rodney L. Wright , Director of HIV Programs, Albert Einstein College of Medicine; and, Dr. Martina C. Fuchs , Founder/CEO, Real Medicine Foundation.
“AHF, together with hundreds of AIDS medical providers and advocates, urges Dr. Chan and WHO to put an end to the harmful use of sub-standard single-dose HIV treatment for expectant mothers and their newborns,” said Michael Weinstein, President of AIDS Healthcare Foundation, which spearheaded the effort. “Study after study has linked the use of single-dose treatments to viral resistance, jeopardizing the effectiveness of future treatment and lowering the chances of a patient’s survival. Accepting the status quo and treating expectant mothers and infants in low-income countries with low-quality therapy - especially as the number of people accessing treatment increases - has dire consequences and is a practice that must end.”
At issue with changing the standard of care are clinical efficacy and fairness. Numerous studies have shown that a short-course, single-dose regimen can raise the risk of viral resistance and jeopardize the effectiveness of future treatment for the mother as well as the child if transmission prevention fails and treatment is needed. Just one example: a recent study comparing anti-HIV treatment regimens - ” DSMB Finds Ritonavir-boosted Lopinavir Superior to Nevirapine in HIV-positive Women Who Previously Took Single-dose Nevirapine,” published on October 28, 2008 as a bulletin in the National Institute of Allergy and Infectious Diseases - demonstrates the ineffectiveness of Nevirapine to treat HIV-infected women who previously took single-dose Nevirapine to avoid transmitting HIV to their newborns.
The rate of mother-to-child HIV transmission has been reduced drastically in high-income countries. The largest study of mother-to-child transmission rates to date, published in 2008 in the journal AIDS , found that if appropriate full-course treatment is administered, 99% of babies were born uninfected with HIV. Yet several hundred thousand babies are born with HIV annually because their mothers do not have access to this same standard of care. An estimated 90% of these infections occur in sub-Saharan Africa.
“It is simply unacceptable to continue a practice that endangers the lives of mothers and infants while low-cost full-course treatment is available,” said Terri Ford , Director of Global Advocacy for AIDS Healthcare Foundation. “While the current WHO guidelines acknowledge the risk of viral resistance, single-dose therapy remains a recommended method. Since most developing countries rely on the guidelines to help shape health policy, WHO must lead the way toward widespread implementation of full-course therapy for all expectant mothers and infants. The health outcomes of thousands of women would be vastly improved and the lives of thousands of children could be saved. It is wrong to save babies only to make them orphans.”
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child
Full Post: Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV
Scientists at the University of Liverpool have developed a therapy programme to treat depression in women in developing countries. Although depression is a major health problem world-wide, experts say its impact is greatest in developing countries where 80% of the population live. Often there are no resources available to treat sufferers. Professor Atif Rahman
Full Post: Study improves recovery for mothers with depression
Scientists at the University of Liverpool have developed a therapy programme to treat depression in women in developing countries. Although depression is a major health problem world-wide, experts say its impact is greatest in developing countries where 80% of the population live. Often there are no resources available to treat sufferers. Professor Atif Rahman from
Full Post: Scientists create therapy programme to treat depression in women in developing countries
“Time poor” single mothers come surprisingly close in the number of hours they spend caring for their children compared to married mothers, and the difference is explained almost entirely by socio-economic factors and the kind of jobs they hold, say University of Maryland sociologists in a new study. The researchers conclude public policy focuses too
Full Post: Study looks at amount of time single mothers are able to give their children
A course of water aerobics classes has been shown to reduce the amount of pain-killing medication women request during labor. Research published in BioMed Central’s open access journal Reproductive Health has shown that, as well as being safe, the gentle exercise has the benefit of making it easier to give birth. Rosa Pereira led a
Full Post: Water aerobics make it easier to give birth